SBIX holdings
As of , SBIX (Invesco NASDAQ Biotech UCITS ETF, ISIN IE00BQ70R696) has 239 holdings on our record. The fund reports 244 positions in all. Weights are shares of the whole fund.
- Holdings
- 239
- 244 reported in all
- Ten largest
- 48.2%
- of the whole fund
- Effective number of holdings
- 29
- As concentrated as this many equal-sized holdings (how it is worked out)
- Largest holding
- 9.0%
- Gilead Sciences
Largest holdings
| Rank by weight# | Holding | Weight as a percentage of the fund |
|---|---|---|
| 1 | Gilead SciencesGILD | 9.03% |
| 2 | AmgenAMGN | 8.55% |
| 3 | Vertex PharmaceuticalsVRTX | 7.84% |
| 4 | Regeneron PharmaceuticalsREGN | 6.19% |
| 5 | ModernaMRNA | 5.95% |
| 6 | Revolution MedicinesRVMD | 2.43% |
| 7 | BiogenBIIB | 2.38% |
| 8 | IlluminaILMN | 2.04% |
| 9 | Royalty Pharma · Class ARPRX | 1.97% |
| 10 | Roivant SciencesROIV | 1.86% |
The fund also holds 5 positions of under 0.005% each, about 0.0% of the fund together. They are not listed one by one.
All holdings
The fund publishes 244 holdings; the ten largest make up 48.2% of it.
Create a free account to see the full holdings list
Sign-up takes an email address. There is no card to enter and nothing to pay.
As of , holdings as published
More:SBIX: key facts, returns and chargesCompare what it holds with another fundHoldings overlapHow overlap is measured
Holdings and weights are as published on 12/11/2026 and change as the fund trades. This is information, not advice.